ECSP088389A - Formulas de infantes que contiene acido docosahexaenoico y luteína - Google Patents

Formulas de infantes que contiene acido docosahexaenoico y luteína

Info

Publication number
ECSP088389A
ECSP088389A EC2008008389A ECSP088389A ECSP088389A EC SP088389 A ECSP088389 A EC SP088389A EC 2008008389 A EC2008008389 A EC 2008008389A EC SP088389 A ECSP088389 A EC SP088389A EC SP088389 A ECSP088389 A EC SP088389A
Authority
EC
Ecuador
Prior art keywords
acid
luteine
infant formulas
formulas containing
lutein
Prior art date
Application number
EC2008008389A
Other languages
English (en)
Inventor
Bridget Barrett-Reis
Pamela T Price
Amy Mackey
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37771124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP088389(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ECSP088389A publication Critical patent/ECSP088389A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/80—Geriatric
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Dairy Products (AREA)

Abstract

El presente invento está dirigido a las formulas para bebes que incluyen grasa, proteína, carbohidrato, vitaminas, y minerales, incluyendo el ácido docosahexaenoico y por lo menos aproximadamente 50 mcg/litro de luteína, donde la relación de peso de la luteína (mcg) con el ácido docosahexaenoico (mg) es de aproximadamente 1:2 a aproximadamente 10:1. El presente invento se dirige también a los métodos que utilizan las formulas para promover la salud retinal y el desarrollo de la visión en los bebes, incluyendo la reducción del riesgo de retinopatía o condición de prematuros en los bebes, y protegerlos contra efectos dañinos de luz natural o artificial excesiva en los ojos de los bebes.
EC2008008389A 2005-10-26 2008-04-21 Formulas de infantes que contiene acido docosahexaenoico y luteína ECSP088389A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73028305P 2005-10-26 2005-10-26
PCT/US2006/041303 WO2007050521A2 (en) 2005-10-26 2006-10-23 Infant formulas containing docosahexaenoic acid and lutein

Publications (1)

Publication Number Publication Date
ECSP088389A true ECSP088389A (es) 2008-06-30

Family

ID=37771124

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008389A ECSP088389A (es) 2005-10-26 2008-04-21 Formulas de infantes que contiene acido docosahexaenoico y luteína

Country Status (22)

Country Link
US (1) US7829126B2 (es)
EP (2) EP2283736B1 (es)
JP (2) JP5473330B2 (es)
KR (2) KR101302629B1 (es)
CN (3) CN101299933B (es)
AU (1) AU2006306366B2 (es)
BR (1) BRPI0617692A2 (es)
CA (2) CA2747281A1 (es)
CR (1) CR9888A (es)
DK (2) DK1945045T3 (es)
EC (1) ECSP088389A (es)
ES (2) ES2552674T3 (es)
HN (1) HN2008000653A (es)
IL (2) IL190479A (es)
MX (1) MX347958B (es)
MY (2) MY146618A (es)
NI (1) NI200800129A (es)
RU (1) RU2445796C2 (es)
SV (1) SV2008002886A (es)
TR (1) TR201808714T4 (es)
WO (1) WO2007050521A2 (es)
ZA (1) ZA200802949B (es)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228392A1 (en) * 2002-06-06 2003-12-11 Wyeth Infant formula compositions containing lutein and zeaxanthin
EP1864654A1 (en) * 2002-06-06 2007-12-12 Wyeth a Corporation of the State of Delaware Infant formula compositions containing lutein and zeaxanthin
CA2537452C (en) * 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
EP1888081B1 (en) 2005-05-23 2016-12-28 Massachusetts Institute of Technology Compositions containing pufa and methods of use thereof
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
US20070166354A1 (en) * 2005-10-26 2007-07-19 Bridget Barrett-Reis Method of reducing the risk of retinopathy of prematurity in preterm infants
EP1800675B1 (en) * 2005-12-23 2011-05-18 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins, manganese and/or molybden and nucleosides/nucleotides for treating dementia
WO2008143642A2 (en) * 2006-11-09 2008-11-27 Children's Medical Center Corporation Methods of treating and preventing ocular neovascularization with omega-3 polyunsaturated fatty acids
AU2008300328A1 (en) * 2007-09-19 2009-03-26 Ophthalmopharma Ag Nutritional supplement formulations and fortified foods comprising such supplements
WO2009057994A1 (en) * 2007-11-02 2009-05-07 N.V. Nutricia Unit dosage for brain health
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
WO2009098186A1 (en) * 2008-02-04 2009-08-13 Novartis Ag Organic compounds
CN101548698B (zh) * 2008-04-03 2012-03-14 光明乳业股份有限公司 母乳化配方牛奶及其制备方法
CN101595977B (zh) † 2008-06-02 2013-04-03 浙江医药股份有限公司新昌制药厂 有益于眼睛明视持久度的配方食品及其应用
JP2010126495A (ja) * 2008-11-28 2010-06-10 Morinaga Milk Ind Co Ltd 母乳添加用粉末
TW201121431A (en) * 2009-12-01 2011-07-01 Abbott Lab Soy protein-based nutritional formula with superior stability
EP2488042B1 (en) * 2010-11-02 2013-10-02 Abbott Laboratories Stable concentrated liquid human milk fortifier
WO2012091542A1 (en) 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
CN103384478B (zh) 2010-12-29 2016-11-23 雅培制药有限公司 降低婴儿、幼儿或儿童的坏死性小肠结肠炎、腹痛和短肠综合征的发病率的方法
BR112013016903A2 (pt) 2010-12-31 2019-09-24 Abbott Lab oligossacarídeos de leite humano para modular inflamação
BR112013016587A2 (pt) 2010-12-31 2016-09-27 Abbott Lab formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas
CA2822219C (en) 2010-12-31 2020-12-29 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
MY196432A (en) 2010-12-31 2023-04-10 Abbott Lab Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
DK2658399T4 (da) 2010-12-31 2024-03-25 Abbott Lab Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion
BR112013016606A2 (pt) 2010-12-31 2016-09-27 Abbott Lab processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
US20120269929A1 (en) * 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
PH12014500185A1 (en) 2011-07-22 2019-10-11 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
HK1199607A1 (en) 2011-08-29 2015-07-10 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
SG11201403712XA (en) * 2011-12-27 2014-10-30 Abbott Lab Use of reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life
WO2013138157A1 (en) * 2012-03-14 2013-09-19 Abbott Laboratories Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
RU2484828C1 (ru) * 2012-04-11 2013-06-20 Анна Викторовна Филимонова Витаминно-минеральное средство: порошок для приготовления раствора для внутреннего применения
TW201440654A (zh) * 2012-12-18 2014-11-01 Abbott Lab 含有低致敏蛋白質及葉黃素之液態濃縮人乳強化劑
CN102986876B (zh) * 2012-12-26 2014-09-03 光明乳业股份有限公司 一种儿童营养奶昔粉
SG11201507217PA (en) * 2013-03-13 2015-10-29 Abbott Lab Method of enhancing bioavailability of dha and other lipid-soluble nutrients
WO2014159967A1 (en) 2013-03-13 2014-10-02 Abbott Laboratories A composition for enhancing newborn infant cognitive, brain and/or cns development and method of using same
HK1219027A1 (zh) * 2013-03-13 2017-03-24 Abbott Laboratories 增强後代的中枢神经系统发育的产前和哺乳补充剂
EP2983517A1 (en) 2013-03-13 2016-02-17 Abbott Laboratories Infant nutritional product with rrr alpha-tocopherol
US11730704B2 (en) * 2013-03-28 2023-08-22 Dsm Ip Assets B.V. Lutein composition suitable for infant food formulations
JP6375296B2 (ja) * 2013-07-10 2018-08-15 ライオン株式会社 脳機能改善用内服組成物、脳内アミロイドβ蓄積抑制用内服組成物、脳機能改善用食品組成物及び脳内アミロイドβ蓄積抑制用食品組成物
EP3043658B1 (en) * 2013-08-29 2019-11-20 Abbott Laboratories Nutritional composition having lipophilic compounds with improved solubility and bioavailability
EP3068386A1 (en) 2013-11-12 2016-09-21 Abbott Laboratories Uses of nutritional compositions including natural vitamin e, and polyunsaturated fatty acid
US20170086481A1 (en) * 2014-06-03 2017-03-30 Abbott Laboratories Nutritional compositions comprising a lipophilic active ingredient
WO2016086128A1 (en) * 2014-11-25 2016-06-02 Abbott Laboratories Method of improving visual processing, visual acuity, or both by administering compositions comprising rrr-alpha-tocopherol and carotenoid to infants
WO2016086157A1 (en) * 2014-11-26 2016-06-02 Abbott Laboratories Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein
JP6071988B2 (ja) * 2014-12-09 2017-02-01 国立大学法人北海道大学 身体活動促進剤
JP6646368B2 (ja) * 2015-06-25 2020-02-14 株式会社東洋新薬 網膜保護組成物
EP3328214B1 (en) 2015-07-29 2020-04-01 Abbott Laboratories Nutritional products having improved lipophilic solubility and bioavailability in an easily mixable form
CN106668835A (zh) * 2015-11-06 2017-05-17 北京康爱营养科技股份有限公司 一种用于肿瘤治疗的肠内营养剂及其制备方法
CN106890312A (zh) * 2015-12-18 2017-06-27 北京康爱营养科技股份有限公司 一种适用于肝癌患者的肠内营养剂及其制备方法
CN105520137B (zh) * 2015-12-21 2018-03-06 北京东方红航天生物技术股份有限公司 一种具有缓解视疲劳和保护视力功能的保健食品
WO2018204670A1 (en) * 2017-05-04 2018-11-08 The Board Of Trustees Of The Leland Stanford Junior University Neurodevelopment-promoting food compositions and kits, systems and methods related thereto
US20220039449A1 (en) * 2018-09-25 2022-02-10 Societe Des Produits Nestle S.A. Gender specific synthetic nutritional compositions and nutritional systems comprising them
CN109793044A (zh) * 2019-03-21 2019-05-24 贝因美（杭州）食品研究院有限公司 一种适用于早产/低出生体重婴儿食用的配方奶粉及其制备方法
US12005083B1 (en) 2019-06-24 2024-06-11 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US11849747B1 (en) * 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
CN110236189A (zh) * 2019-06-25 2019-09-17 海普诺凯营养品有限公司 一种保护视力的组合物及其制备方法和应用
JP6736137B2 (ja) * 2019-07-11 2020-08-05 株式会社東洋新薬 網膜保護組成物
IT201900023016A1 (it) * 2019-12-04 2021-06-04 Alesco Srl Formulazioni comprendenti un minerale e un polisaccaride, loro composizioni e loro uso nella supplementazione di detto minerale
TR202002876A2 (tr) * 2020-02-25 2021-09-21 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Pedi̇atri̇k sağliğin i̇yi̇leşti̇ri̇lmesi̇ne yöneli̇k besi̇n kompozi̇syonlari
CN115461048A (zh) * 2020-03-11 2022-12-09 博士伦爱尔兰有限公司 包含areds和维生素b复合物的用于眼睛健康的组合物和方法
CN116234450A (zh) * 2020-05-15 2023-06-06 Eaf公司 婴儿配制品
AU2022345465A1 (en) * 2021-09-17 2024-03-21 N.V. Nutricia Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases
EP4590134A1 (en) 2022-09-23 2025-07-30 N.V. Nutricia A process of preparing an enteral nutritional composition
CN116621749B (zh) * 2023-05-24 2026-02-03 中国海洋大学 一种护眼dha-叶黄素酯及其制备方法、应用
WO2025106389A1 (en) * 2023-11-13 2025-05-22 Universitatea De Medicină Şi Farmacie Iluiu Haţieganu New forms of lutein and their uses
WO2025239825A1 (en) * 2024-05-17 2025-11-20 Eyedidit Aktiebolag Substances for treatment of a retinal disease and/or retinal impairment
US12564207B2 (en) 2024-07-08 2026-03-03 Bobbie Baby Inc. Infant formulation comprising olive oil and methods therewith

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2101274C (en) * 1991-01-24 1998-12-15 David J. Kyle Microbial oil mixtures and uses thereof
US6080787A (en) 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
EP1039892B1 (en) 1997-02-21 2004-04-28 Abbott Laboratories Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
JP2002513411A (ja) * 1997-04-04 2002-05-08 ヘンケル コーポレーション 高いバイオアベイラビリティを有するルテインエステル
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6495599B2 (en) 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
DE10030781A1 (de) 2000-06-29 2002-01-17 Hassan Jomaa Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen
US7090862B2 (en) * 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
JP2003026589A (ja) * 2001-07-16 2003-01-29 Naturally Plus:Kk 眼病予防および視覚改善剤
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
US6913778B2 (en) * 2001-12-21 2005-07-05 Wyeth Infant formula compositions comprising increased amounts of alpha-lactalbumin
US20040076691A1 (en) 2002-01-16 2004-04-22 David Haines Anti-inflammatory formulations
AR039170A1 (es) * 2002-03-28 2005-02-09 Bio Dar Ltd Co-granulos de dha y romero y metodos de uso
US20030228392A1 (en) * 2002-06-06 2003-12-11 Wyeth Infant formula compositions containing lutein and zeaxanthin
US6649195B1 (en) * 2002-07-11 2003-11-18 Vitacost.Com, Inc. Eyesight enhanced maintenance composition
CN1481829A (zh) * 2002-09-09 2004-03-17 高宾生 万寿菊花粉保健食品
US7867541B2 (en) * 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
JP2005065525A (ja) * 2003-08-20 2005-03-17 Koyo Shokai:Kk ルテインおよびブルーベリー含有飲料
DE602005003201T2 (de) * 2004-01-16 2008-11-06 Indus Biotech Pvt. Ltd. Verfahren zur isolierung, aufreinigung und formulierung einer stabilen handelsüblichen luteinpaste aus oleoresin
WO2005087208A2 (en) 2004-03-10 2005-09-22 Trustees Of Tufts College Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
US7887847B2 (en) 2004-05-08 2011-02-15 Paul Jr Edward L Nutritional supplement for treatment of ocular diseases
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
FR2882894B1 (fr) 2005-03-11 2009-04-03 Larena Sa Composition alimentaire suppletive
WO2006116755A2 (en) 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
US20060270739A1 (en) * 2005-04-28 2006-11-30 Trustees Of Tufts College Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein

Also Published As

Publication number Publication date
JP5473330B2 (ja) 2014-04-16
CR9888A (es) 2008-09-04
WO2007050521A2 (en) 2007-05-03
ZA200802949B (en) 2009-06-24
MY146618A (en) 2012-09-14
AU2006306366B2 (en) 2011-05-12
DK1945045T3 (en) 2016-01-11
CN103211225A (zh) 2013-07-24
JP2009513641A (ja) 2009-04-02
US20070098849A1 (en) 2007-05-03
TR201808714T4 (tr) 2018-07-23
RU2445796C2 (ru) 2012-03-27
MX347958B (es) 2017-05-19
KR20080069976A (ko) 2008-07-29
HK1117351A1 (zh) 2009-01-16
CA2747281A1 (en) 2007-05-03
CN101299933A (zh) 2008-11-05
RU2011148962A (ru) 2013-06-10
HN2008000653A (es) 2010-11-24
NI200800129A (es) 2011-12-15
JP5572645B2 (ja) 2014-08-13
IL190479A (en) 2012-02-29
IL190479A0 (en) 2008-11-03
EP1945045B1 (en) 2015-10-21
US7829126B2 (en) 2010-11-09
HK1187499A1 (zh) 2014-04-11
IL217636A (en) 2017-09-28
ES2682074T3 (es) 2018-09-18
CA2625001C (en) 2011-12-20
RU2008120696A (ru) 2009-12-10
CN103211225B (zh) 2015-11-18
BRPI0617692A2 (pt) 2011-08-02
WO2007050521A3 (en) 2007-08-09
CN101299933B (zh) 2013-04-24
EP2283736B1 (en) 2018-05-30
MY158307A (en) 2016-09-30
CN103169093A (zh) 2013-06-26
EP2283736A1 (en) 2011-02-16
KR101302629B1 (ko) 2013-09-03
ES2552674T3 (es) 2015-12-01
CA2625001A1 (en) 2007-05-03
KR101106944B1 (ko) 2012-01-19
KR20110110376A (ko) 2011-10-06
AU2006306366A1 (en) 2007-05-03
DK2283736T3 (en) 2018-06-25
JP2012131802A (ja) 2012-07-12
SV2008002886A (es) 2016-05-16
EP1945045A2 (en) 2008-07-23

Similar Documents

Publication Publication Date Title
ECSP088389A (es) Formulas de infantes que contiene acido docosahexaenoico y luteína
AR034220A1 (es) Complemento nutricional para tratar la degeneracion macular
ES2832734T3 (es) Mejoras en el rendimiento visual o relacionadas con este
AR064332A1 (es) Composicion suplementaria nutricional o dietetica que fortalece y promueve la salud retinal
CL2004001550A1 (es) Formula para infantes o para etapa siguiente del crecimiento, que comprende proteinas, lipidos, carbohidratos y un probiotico, en donde la fuente de lipidos incluye al menos un lc-pufa, y sus usos.
MX2016005408A (es) Ficomposiciones para prevenir o tratar alergias en infantes a partir de o alimentados por madres no secretoras mediante el suministro de oligosacaridos fucosilados, particularmente entre los niños en riesgo o nacidos por cesarea.
ES2524776T3 (es) Composiciones de vitamina D y método de administración a un ser humano
CO6160277A2 (es) Alimentacion de larga duracion -mayores de edad
BR0215904A (pt) Métodos e composições para prover glutamina
ES2550338T3 (es) Composición antioxidante para la reducción de las causas de la capacidad reproductiva masculina reducida
Kapoor Safety of studies analysing clinical benefit of amygdalin
ES3054989T3 (en) Methods for improvement of visual function and compositions used therein
CA2746902C (en) A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement
ES2754279T3 (es) Uso de carotenoides de xantofila para mejorar el rendimiento visual y la eficiencia neuronal
WO2019040459A3 (en) Composition and nutritional supplement made therefrom
BR112022008956A2 (pt) Composições para uso na redução de dor e/ou percepção de dor em bebês e crianças pequenas
Sheck et al. Selenium and ocular health in New Zealand
GT200800312A (es) Fórmulas para lactantes que contienen ácido docosahexenoico y luteí na
KR20120110955A (ko) 타우린, 이노시톨, 비타민ｃ, 비타민 ｂ군 및 요오드화칼륨을 주성분으로 함유하는 기능성 음료조성물
CL2008002650A1 (es) Rango de productos alimenticios para infantes donde cada producto incluye menos de 10% de energia total del producto proporcionado por el azucar incorporado; regimen alimenticio para alcanzar las necesidades nutraicionales del infante durante diferentes etapas de desarrollo al administrar un rango de productos; usos.
ES2347431T3 (es) Aceite comestible con vitaminas añadidas que favorecen la asimilacion del calcio.
Richer A primer on ocular nutrition: these nutrients can prevent the progression to advanced AMD or provide other ocular and systemic health benefits
Prasad Lutein and eye health: The connection that you can’t ignore
MX2024003744A (es) Composiciones para el uso.
Sher Commentary: Vitamin D Deficiency Associated with Cognitive Functioning in Psychotic Disorders